Estrella Immunopharma, Inc. Warrant Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Estrella Immunopharma, Inc. Warrant Share Price Chart

$0.00$0.00

Estrella Immunopharma, Inc. Warrant Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-0.35	Revenue (TTM) N/A	Return On Equity (TTM) 126.02%
Profit Margin N/A	Debt to Equity -1.31	Quarterly Earnings Growth YoY -42.18%

Estrella Immunopharma, Inc. Warrant Quarterly Profit & Loss

All figures in USD

Particulars	Dec 2023	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit	-$1.02M	-$469530.00	-$3.38M	-$2.10M	-$5.54M	-$4.80M
Net Profit Margin	N/A	N/A	N/A	N/A	N/A	N/A
Income Change	N/A	54.00%	-619.17%	37.68%	-163.50%	13.41%

Estrella Immunopharma, Inc. Warrant Annual Profit & Loss

All figures in USD

Particulars	2021	2022	2025
Revenue	N/A	N/A	N/A
Net Profit	-$1.52	-$996104.00	-$13.06M
Net Profit Margin	N/A	N/A	N/A
Income Change	N/A	-65533057.89%	-1211.46%

About Estrella Immunopharma, Inc. Warrant

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Estrella Immunopharma, Inc. Warrant Historical Returns

Month	Open	Close	Change %

ESLAW Share Price FAQs

What is Estrella Immunopharma, Inc. Warrant share price today?

Estrella Immunopharma, Inc. Warrant share price today is $0.00 as on August 10, 2026 at 12:11 pm IST.

What is the 52 week high and 52 week low of Estrella Immunopharma, Inc. Warrant stock?

52 week high/low data for Estrella Immunopharma, Inc. Warrant is currently unavailable.

What is ESLAW's net income for the last quarter?

ESLAW's net income for the last quarter is -0.00B USD.

Can I buy ESLAW shares in India?

Yes. You can buy ESLAW in India by opening an international trading account.